As a European preclinical neurology contract research organization (CRO), InnoSer provides you with a portfolio of Alzheimer’s disease mouse models that are relevant for performing preclinical efficacy research studies. By choosing InnoSer as your partner CRO, you will work alongside our expert study directors who take a collaborative approach for your study, accommodating your study timelines and budget needs.  InnoSer’s neurology expert team possesses relevant experience in working with multiple therapy types ranging from small molecules, peptides, enzymes, oligonucleotides, gene therapy (viral vectors – e.g.. AAVs) and immunotherapies (antibody/vaccine immunotherapies). 

InnoSer offers multiple Alzheimer’s disease mouse models for preclinical research, including APP transgenic mice as well as transgenic Tau and Tau seeding mouse models using recombinant and/or patient-derived seeds. However, as each model is unique, modelling distinct pathophysiological aspects of Alzheimer’s disease, we recommend you discuss the most appropriate model with our neurology study directors.